Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
Oncology Today with Dr Neil Love
00:00
NIAGARA trial quality-of-life findings
Terence Friedlander summarizes NIAGARA: perioperative dervalumab added to cis/gem improved outcomes without QoL detriment.
Play episode from 00:29
Transcript
